PBFT02 administration resulted in improvements in two disease progression biomarkers, as compared to natural history, reducing brain atrophy and stabilizing plasma NfL levels FDA feedback from recent ...

PHILADELPHIA, April 20, 2026 (GLOBE NEWSWIRE)-- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, ...

Shares of Solid Biosciences (SLDB) fell on Wednesday following a brief trading halt as the gene therapy developer announced additional data from an ongoing Phase 1/2 clinical trial for SGT-003, its ...

More than 100 researchers call for safeguards on high-risk biological datasets to prevent AI misuse, which could create deadly pathogens. Artificial intelligence (AI) models for biology rely heavily ...

Upstream Bio will progress verekitug to a registrational Phase III trial in severe asthma. Image credit: Victoria Nevzorova via ShutterStock.com. Upstream Bio’s stock value took a 47% downturn ...

Nuvation Bio earns a modest Buy at ~$5, supported by the steady adoption of IBTROZI, its lead asset, by patients and prescribers alike during the last 7 months. IBTROZI's patient starts stabilized at ...

Jan 6 (Reuters) - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic data to discover new drug candidates to send into human ...

For many years, the landscape of data center innovation has been dominated by solid-state electronics. The relentless pursuit of faster chips, denser racks and larger facilities has been the mantra ...

Results from the Precision-T study showed Orca-T significantly improved survival free from chronic GvHD in patients with AML, ALL and MDS compared to a conventional allogeneic hematopoietic stem cell ...

Trial shows GRI-0621 improved lung function with signs of fibrosis resolution GRI Bio has announced positive topline results from its phase 2a clinical trial evaluating GRI-0621 in idiopathic ...

South Korea's "National Integrated Bio Big Data Construction Project," aimed at innovating the bio industry and strengthening medical sovereignty, has been sluggish, according to data from the Korea ...